GLP-1 drugs may prevent deadly heart complications after heart attack

Researchers from the University of Bristol and University College London (UCL) discovered that GLP-1 receptor agonists (the class including semaglutide in Ozempic/Wegovy and tirzepatide in Mounjaro) can prevent a deadly post-heart attack complication called “no-reflow” — which strikes up to 50% of patients even after doctors successfully reopen the main blocked artery. sciencedirect.com frontiersin.org What … Read more

Study links toilet smartphone use to nearly 50% higher hemorrhoid risk

Trending: Digital Habits Under Scrutiny In an era where smartphones are constant companions, a new study has raised alarms about their impact on health in an unexpected place: the bathroom. Research published on September 3, 2025, in the open-access journal PLOS One reveals that using a smartphone while on the toilet increases the risk of … Read more